Related Experiment Video
Updated: Jun 6, 2026
06:56
Isolation, Culture, and Adipogenic Induction of Stromal Vascular Fraction-derived Preadipocytes from Mouse Periaortic Adipose Tissue
Published on: July 21, 2023
Systemic adiponectin malfunction as a risk factor for cardiovascular disease.
Wayne Bond Lau1, Ling Tao, Yajing Wang
1Department of Emergency Medicine, Thomas Jefferson University, 1020 Sansom Street, Philadelphia, PA 19107, USA.
Antioxidants & Redox Signaling
|November 25, 2010
Summary
Adiponectin (Ad), a hormone regulating metabolism, plays a crucial role in cardiovascular health. Low adiponectin levels are linked to increased cardiovascular disease risk, highlighting its therapeutic potential.
Area of Science:
- Endocrinology
- Metabolic Regulation
- Cardiovascular Science
Background:
- Adiponectin (Ad) is a key metabolic hormone produced by adipose tissue.
- It circulates in various oligomeric forms (trimers, hexamers, multimers) and binds to specific receptors.
- Ad influences metabolic, anti-inflammatory, vascular protective, and anti-ischemic pathways, including AMP-activated protein kinase (AMPK).
Purpose of the Study:
- To review the role of adiponectin malfunction and deficiency in cardiovascular disease.
- To explore adiponectin resistance as a novel cardiovascular injury risk factor.
- To provide insights into future adiponectin research and therapeutic applications.
Main Methods:
- Literature review of adiponectin's role in metabolic and cardiovascular pathology.
- Analysis of clinical observations linking hypoadiponectinemia to obesity, cardiovascular disease, and insulin resistance.
- Examination of evidence for adiponectin resistance in cardiovascular injury.
Main Results:
- Hypoadiponectinemia is associated with obesity, cardiovascular disease, and insulin resistance.
- Adiponectin deficiency contributes to atherosclerosis, endothelial dysfunction, and cardiac injury.
- Adiponectin resistance is emerging as a significant risk factor for cardiovascular injury.
Conclusions:
- Adiponectin plays a vital role in cardiovascular protection through various mechanisms.
- Understanding adiponectin deficiency and resistance is critical for assessing cardiovascular disease risk.
- Further research into adiponectin holds promise for novel therapeutic strategies for cardiovascular conditions.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:27Psychoneuroimmunology: Cardiovascular Disease
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...